Expert Review of Clinical Immunology
短名 | Expert Rev. Clin. Immunol. |
Journal Impact | 4.07 |
国际分区 | IMMUNOLOGY(Q2) |
期刊索引 | SCI Q2中科院 3 区 |
ISSN | 1744-666X, 1744-8409 |
h-index | 71 |
国内分区 | 医学(3区)医学免疫学(3区) |
临床免疫学专家评论 (ISSN 1744-666X) 就临床免疫学中新的治疗和诊断方式的表现提供专家分析和评论。临床免疫学专家评审国际编辑咨询小组的成员是其专业领域的前沿。该小组与我们专门的编辑团队合作,确定最重要和最热门的评论主题以及最适合提供评论和分析的相应专家。所有文章都经过严格的同行评审,完成的评审为临床免疫学的决策提供了重要的贡献。文章重点关注以下关键领域:• 特定免疫疾病的治疗概述,突出了新药的最佳治疗和前景• 新批准的治疗药物的性能和益处• 新诊断方法• 筛选和患者分层• 药物经济学研究• 现有的新治疗适应症治疗• 不良反应、发生和减少• 药物在接近监管批准的后期试验中的前景• 新的治疗策略• 流行病学研究• 治疗指南的评论和比较 主题包括感染和免疫、炎症、宿主防御机制、先天性和获得性免疫缺陷、过敏反应和过敏、全身免疫疾病、器官特异性炎症性疾病、移植免疫学、内分泌学和糖尿病、癌症免疫学、神经免疫学和血液学疾病。
期刊主页投稿网址涉及主题 | 医学生物免疫学内科学遗传学病理疾病化学生物化学免疫系统抗体重症监护医学外科心理学 |
出版信息 | 出版商: Taylor and Francis Ltd.,出版周期: Bimonthly,期刊类型: journal |
基本数据 | 创刊年份: 2006,原创研究文献占比: 24.07%,自引率:0.00%, Gold OA占比: 15.07% |
平均审稿周期 | 网友分享经验:较慢,6-12周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Complement as a major mediator of ANCA vasculitis and a target for precision therapy
2024-9-13
Isolation and analysis of the exosomal membrane proteins in bullous pemphigoid
2024-9-4
Single-cell RNA sequencing: an emerging tool revealing dysregulated innate and adaptive immune response at single cell level in kawasaki disease
2024-9-4
Nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in Immunopathology and therapeutic impact of JAK inhibitors
2024-9-3
Predictive value analysis of albumin-related inflammatory markers for short-term outcomes in patients with In-hospital cardiac arrest
2024-9-2
Resveratrol: immunological activity and possible application in children and adolescents with allergic rhinitis.
2024-8-30
Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency
2024-8-29
Spectrum of neurological manifestations, existence of diabetes mellitus, and 5-year mortality and cancer association outcomes in a cohort of Omani patients with positive anti- GAD autoimmunity
2024-8-21
Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors
2024-8-18
Role of tight junction proteins in shaping the immune milieu of malignancies
2024-8-14
Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system
2024-8-13
Recent insights into the impacts of COVID-19 on pediatric asthma
2024-8-13
Prenatal heavy metal exposure and pediatric asthma, allergic rhinitis, atopic dermatitis: a systematic review and meta-analysis
2024-8-12
Behçet disease: epidemiology, classification criteria and treatment modalities
2024-8-11
Molecular genotyping versus serological diagnosis for RH blood group typing in sickle cell patients
2024-8-8
Proteomics approach for biomarker discovery in Kawasaki disease
2024-8-2
Lymphocyte-C-reactive protein ratio combined with albumin upon admission predicts coronary artery dilation and aneurysm formation in pediatric patients with Kawasaki disease: a retrospective cohort study
2024-7-31
Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge
2024-7-30
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies
2024-7-29
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype
2024-7-24
Anakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients
2024-7-23
Pathogen-specific Cell-mediated Immunity to Guide the Management of Cytomegalovirus in Solid Organ Transplantation: state of the art clinical review
2024-7-22
Connecting salivary gland inflammation to specific symptoms in Sjögren’s disease
2024-7-21
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours
2024-7-17
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy
2024-7-16
Changes in health-related quality of life in common variable immunodeficiency: an eight-year journey, including the COVID-19 pandemic
2024-7-12
Treatment intensification in kawasaki disease - current perspectives
2024-7-9
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations
2024-7-2
Efficacy and safety of subcutaneous immunotherapy with polymerized allergen mixtures in polyallergic patients. ARES observational study.
2024-7-2
Harnessing the power of AI-based models to accelerate drug discovery against immune diseases
2024-7-1
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications
2024-6-26
Sicca syndrome/Sjögren’s disease associated with cancer immunotherapy: a narrative review on clinical presentation, biomarkers and management
2024-6-25
Advancements in immunotherapy for advanced esophageal squamous cell carcinoma: a comprehensive review of current strategies and future directions
2024-6-17
Salivary gland biopsy as a prognostic tool in Sjögren’s syndrome
2024-6-17
Machine learning and artificial intelligence within pediatric autoimmune diseases: applications, challenges, future perspective
2024-6-14
Immunological alterations in the endothelial barrier: a new predictive and therapeutic paradigm for sepsis
2024-6-8
The role of histone deacetylases in inflammatory respiratory diseases: an update
2024-6-4
The effect of intense pulsed light combined with topical 0.05% cyclosporin a eyedrops in the treatment of Sjögren’s syndrome related dry eye
2024-5-27
Immunology and targeted therapy in Castleman disease
2024-5-27
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease
2024-5-21
Updating on pregnancy in Rheumatoid Arthritis
2024-5-20
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity
2024-5-16
Can we define difficult-to-treat systemic sclerosis?
2024-5-14
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
2024-5-13
Molecular investigations on T cell subsets in patients affected by Hypomorphic <i>DCLRE1C</i> Mutation
2024-5-9
Navigating the crossroads: asthma, trained immunity, and infection susceptibility.
2024-5-9
Functional roles of microRnas in vasculogenic mimicry and resistance to therapy in human cancers: an update
2024-5-9
Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategies
2024-5-1
How could our genetics impact COVID-19 vaccine response?
2024-4-27
Exploring the relationship between house dust mites and asthma
2024-4-23
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远